Alarmins in cutaneous malignant melanoma: An updated overview of emerging evidence on their pathogenetic, diagnostic, prognostic, and therapeutic role
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Alarmins show a dual role in malignant cutaneous melanoma, impacting its understanding, diagnosis, and treatment. Further research is crucial for harnessing their potential in precision dermato-oncology.
Area Of Science
- Dermato-oncology
- Cancer immunology
Background
- Malignant cutaneous melanoma incidence is rising globally, necessitating novel therapeutic strategies.
- Alarmins are emerging as key players in melanoma pathogenesis, diagnosis, and prognosis.
- The complex, dual role of alarmins in melanoma requires thorough investigation.
Purpose Of The Study
- To critically analyze the current evidence on the dichotomous role of alarmins in malignant cutaneous melanoma.
- To provide an up-to-date overview of alarmin involvement in melanoma.
- To explore novel therapeutic frontiers, including personalized and precision medicine approaches.
Main Methods
- Comprehensive literature review of preclinical and clinical findings.
- Focus on studies published in the PubMed database within the last five years.
- Analysis of emerging evidence on alarmin function and therapeutic potential.
Main Results
- Alarmins exhibit a contradictory, dual role in malignant cutaneous melanoma.
- Evidence suggests alarmins are involved in disease pathogenesis, diagnosis, and prognosis.
- Early successes in other fields indicate potential for alarmin-based precision therapies.
Conclusions
- Understanding the dichotomous role of alarmins is critical for advancing melanoma treatment.
- Alarmins represent a promising area for developing innovative diagnostic and therapeutic strategies.
- Personalized and precision medicine approaches targeting alarmins could revolutionize dermato-oncology.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.